glp-1 and bone density Study reveals exercise RA combination preserves health during weight loss GLP-1 Therapy Risks: Muscle Loss

Ventricular myxomas may mimic aortic or pulmonic valve stenosis, causing syncope

32 Summary DPP-4 inhibitors may have the greatest impact in patients who are early in the disease process

Scientists are also looking into whether they could be used to treat depression, alcoholism, and other conditions

Another factor to consider is whether the potential long term benefits, including weight loss or possible disease improvement, would require continued use of GLP-1 agonist in addition to other IBD treatment options, as this can represent an additional financial or emotional burden on patients.

Review your patient's body surface area (BSA), appropriate HALAVEN dosage, and number of vials required

N Engl J Med 376(23):23002302